Cary, NC, United States of America

Ajoy Velayudhan



 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ajoy Velayudhan: Innovator in Recombinant Protein Production

Introduction

Ajoy Velayudhan is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 6 patents to his name, Velayudhan's work has advanced the understanding and application of CTLA4-Ig and its variants.

Latest Patents

Ajoy Velayudhan's latest patents include innovative methods and compositions for producing CTLA4-Ig. One of his inventions provides mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. This invention also details compositions comprising CTLA4-Ig and formulations thereof. Furthermore, it outlines methods for mass-producing CTLA4-Ig from mammalian cells and for purifying the CTLA4-Ig, enhancing the efficiency of recombinant protein production.

Career Highlights

Throughout his career, Ajoy Velayudhan has worked with prominent companies in the biotechnology sector. He has been associated with Bristol-Myers Squibb Company and Grifols, S.A., where he has contributed to various research and development projects. His expertise in recombinant protein production has been instrumental in advancing therapeutic applications.

Collaborations

Ajoy Velayudhan has collaborated with several professionals in his field, including Kirk J. Leister and Eugene J. Schaefer. These collaborations have fostered innovation and have led to the successful development of new biotechnological solutions.

Conclusion

Ajoy Velayudhan's contributions to the field of biotechnology, particularly in the area of recombinant protein production, have been significant. His patents and collaborations reflect his commitment to advancing scientific knowledge and improving therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…